Daniel C. Adelman M.D., Chief Medical Officer at Aimmune Therapeutics, Inc. (AIMT), sold 10,000 shares at $25.00 ($250K) on 2017-09-25, disclosed to the SEC on 2017-09-27.
Open-market sale of $250k AIMT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AIMT | SELL | 2018-01-16 | $1.5M | — | Filing → |
| AIMT | SELL | 2017-12-29 | $131K | — | Filing → |
| AIMT | SELL | 2017-10-25 | $575K | — | Filing → |